Pharmagreen Biotech is Seeking to Revolutionize Cancer Research with their Cannabis Botany Center

MapableUSA.com: The cannabis industry is worth billions of dollars, and is showing no signs of slowing down with many cannabis related companies now providing crowdfunding investment opportunities to both accredited and non-accredited investors who wish to participate in its growth. It may also help discover cures and treatments for cancer. Pharmagreen Biotech, with their S1 document now effective from the SEC, is one such company targeting cancer research and much more with their vision of multi-purpose Cannabis Botany Centers. In this podcast, company CEO and Director Peter Wojcik explains how he’s using proprietary technology and intellectual property to reach his goal of building these facilities across the nation (and internationally) – and how investors of all sizes can get involved.Become a supporter of this podcast: https://www.spreaker.com/podcast/mapable-usa--3164091/support.